Soleus Capital Master Fund, L.P. 13D and 13G filings for IRadimed Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:35 pm Sale |
2024-09-30 | 13G | IRadimed Corporation IRMD |
Soleus Capital Master Fund, L.P. | 1,000 0.000% |
-642,206 (-99.84%) |
Filing |
| 2024-02-02 09:44 am Sale |
2023-12-31 | 13G | IRadimed Corporation IRMD |
Soleus Capital Master Fund, L.P. | 643,206 5.100% |
-101,798 (-13.66%) |
Filing |
| 2023-02-14 08:16 am Purchase |
2022-12-31 | 13G | IRadimed Corporation IRMD |
Soleus Capital Master Fund, L.P. | 745,004 5.900% |
98,593 (+15.25%) |
Filing |
| 2022-09-01 09:00 am Purchase |
2022-08-29 | 13G | IRadimed Corporation IRMD |
Soleus Capital Master Fund, L.P. | 646,411 5.100% |
646,411 (New Position) |
Filing |